Yi Xing

Company: Seismic Therapeutics

Job title: Senior Director



Structure Empowered IMPACT Platform in the Discovery & Development of Immunoglobulin Sculpting (IgSc) Enzyme & Dual-Cell Bidirectional (DcB) Antibody Drugs for Immunological Diseases 1:45 pm

  • Understanding the structural biology function and IMPACT platform
  • Exploring how structure-based rational design and machine learning design fueled drug discovery and development of IgSc enzyme
  • DcB antibody-antigen structures supporting the development of biologic drugs

day: Day 2

Yi Xing